Howard Yu - NWTN Warrant Chief Officer
| NWTNW Stock | 0.05 0 2.44% |
Insider
Howard Yu is Chief Officer of NWTN Warrant
| Age | 55 |
| Address | Building A1, Dubai, United Arab Emirates |
| Phone | 971 5 0656 3888 |
| Web | https://www.nwtnmotors.com |
Howard Yu Latest Insider Activity
Tracking and analyzing the buying and selling activities of Howard Yu against NWTN Warrant stock is an integral part of due diligence when investing in NWTN Warrant. Howard Yu insider activity provides valuable insight into whether NWTN Warrant is net buyers or sellers over its current business cycle. Note, NWTN Warrant insiders must abide by specific rules, including filing SEC forms every time they buy or sell NWTN Warrant'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Howard Yu over six months ago Acquisition by Howard Yu of 13030 shares of Ball subject to Rule 16b-3 | ||
Howard Yu over a year ago Sale by Howard Yu of 10016 shares of Envista Holdings |
NWTN Warrant Management Efficiency
The company has return on total asset (ROA) of (0.326) % which means that it has lost $0.326 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.2854) %, meaning that it generated substantial loss on money invested by shareholders. NWTN Warrant's management efficiency ratios could be used to measure how well NWTN Warrant manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.14 in 2024. Return On Capital Employed is likely to climb to -0.15 in 2024. At this time, NWTN Warrant's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to climb to about 132.7 M in 2024, whereas Other Current Assets are likely to drop slightly above 11.7 M in 2024.Similar Executives
| Showing other executives | INSIDER Age | ||
| Pr Keisari | Alpha Tau Medical | 77 | |
| Uzi Sofer | Alpha Tau Medical | 54 | |
| Robert Wiesenthal | Blade Air Mobility | 57 | |
| FACC Facc | NewAmsterdam Pharma | 65 | |
| Amnon Gat | Alpha Tau Medical | 49 | |
| Lina Gugucheva | NewAmsterdam Pharma | 37 | |
| Pr Kelson | Alpha Tau Medical | 84 | |
| Peter Chen | NWTN Class B | 54 | |
| Amir Cohen | Blade Air Mobility | 47 | |
| Robert MD | Alpha Tau Medical | 45 | |
| Ronen Segal | Alpha Tau Medical | 51 | |
| Louise Kooij | NewAmsterdam Pharma | 48 | |
| James Finn | NWTN Class B | 59 | |
| Raphi Levy | Alpha Tau Medical | 39 | |
| Brandon Keene | Blade Air Mobility | 38 | |
| FESC MD | NewAmsterdam Pharma | 68 | |
| Annie Neild | NewAmsterdam Pharma | N/A | |
Management Performance
| Return On Equity | -1.29 | |||
| Return On Asset | -0.33 |
NWTN Warrant Leadership Team
Elected by the shareholders, the NWTN Warrant's board of directors comprises two types of representatives: NWTN Warrant inside directors who are chosen from within the company, and outside directors, selected externally and held independent of NWTN. The board's role is to monitor NWTN Warrant's management team and ensure that shareholders' interests are well served. NWTN Warrant's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, NWTN Warrant's outside directors are responsible for providing unbiased perspectives on the board's policies.
| James Finn, Chief Officer | ||
| Aaron Liao, Executive Chairman | ||
| Howard Yu, Chief Officer | ||
| Leo Lin, Principal Officer | ||
| Damon Xian, Principal Finance | ||
| Xiaoguang Sun, Chief Officer | ||
| Peter Chen, Chief Officer | ||
| Alan Wu, Executive CEO |
NWTN Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is NWTN Warrant a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.29 | |||
| Return On Asset | -0.33 | |||
| Operating Margin | (82.85) % | |||
| Number Of Shares Shorted | 19.78 K | |||
| EBITDA | (40.11 M) | |||
| Net Income | (41.25 M) | |||
| Total Debt | 22.78 M | |||
| Book Value Per Share | 0.78 X | |||
| Cash Flow From Operations | (178.37 M) | |||
| Number Of Employees | 103 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for NWTN Stock Analysis
When running NWTN Warrant's price analysis, check to measure NWTN Warrant's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NWTN Warrant is operating at the current time. Most of NWTN Warrant's value examination focuses on studying past and present price action to predict the probability of NWTN Warrant's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NWTN Warrant's price. Additionally, you may evaluate how the addition of NWTN Warrant to your portfolios can decrease your overall portfolio volatility.